Bleichroeder LP - Mar 19, 2025 SCHEDULE 13G/A Report for Evoke Pharma, Inc. Common Shares (EVOK)

Filing Manager
Bleichroeder LP
Reporting Manager
Bleichroeder LP
Security
Evoke Pharma, Inc. Common Shares
Symbol
EVOK
Shares outstanding
8.5M shares
Disclosed Ownership
849K shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
3/21/2025, 07:15 PM
Date of event
Mar 19, 2025
Next filing
Mar 24, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bleichroeder LP 9.99% 849K 849K 0 Andrew Gundlach Andrew Gundlach, Chairman and CEO
Bleichroeder Holdings LLC 9.99% 849K 849K 0 Andrew Gundlach Andrew Gundlach, Chairman and CEO
Andrew Gundlach 9.99% 849K 849K 0 Andrew Gundlach Andrew Gundlach, Individual